Perioperative Quality Initiative consensus statement on postoperative blood pressure, risk and outcomes for elective surgery.
View/ Open
Proof
Embargoed until: 5555-01-01
Embargoed until: 5555-01-01
Volume
122
Pagination
575 - 586
DOI
10.1016/j.bja.2019.01.019
Journal
Br J Anaesth
Issue
Metadata
Show full item recordAbstract
BACKGROUND: Postoperative hypotension and hypertension are frequent events associated with increased risk of adverse outcomes. However, proper assessment and management is often poorly understood. As a part of the PeriOperative Quality Improvement (POQI) 3 workgroup meeting, we developed a consensus document addressing this topic. The target population includes adult, non-cardiac surgical patients in the postoperative phase outside of the ICU. METHODS: A modified Delphi technique was used, evaluating papers published in MEDLINE examining postoperative blood pressure monitoring, management, and outcomes. Practice recommendations were developed in line with National Institute for Health and Care Excellence guidelines. RESULTS: Consensus recommendations were that (i) there is evidence of harm associated with postoperative systolic arterial pressure <90 mm Hg; (ii) for patients with preoperative hypertension, the threshold at which harm occurs may be higher than a systolic arterial pressure of 90 mm Hg; (iii) there is insufficient evidence to precisely define the level of postoperative hypertension above which harm will occur; (iv) a greater frequency of postoperative blood pressure measurement is likely to identify risk of harm and clinical deterioration earlier; and (v) there is evidence of harm from withholding beta-blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors in the postoperative period. CONCLUSIONS: Despite evidence of associations with postoperative hypotension or hypertension with worse postoperative outcome, further research is needed to define the optimal levels at which intervention is beneficial, to identify the best methods and timing of postoperative blood pressure measurement, and to refine the management of long-term antihypertensive treatment in the postoperative phase.
Authors
McEvoy, MD; Gupta, R; Koepke, EJ; Feldheiser, A; Michard, F; Levett, D; Thacker, JKM; Hamilton, M; Grocott, MPW; Mythen, MGCollections
Language
Copyright statements
Related items
Showing items related by title, author, creator and subject.
-
Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC)
Rahimi, K; Canoy, D; Nazarzadeh, M; Salimi-Khorshidi, G; Woodward, M; Teo, K; Davis, BR; Chalmers, J; Pepine, CJ; Blood Pressure Lowering Treatment Trialists’ Collaboration. (BMJ Journals, 2019-05)INTRODUCTION: Previous research from the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC) and others has shown that pharmacological blood pressure (BP)- lowering substantially reduces the risk of major ... -
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
Rahimi, K; Bidel, Z; Nazarzadeh, M; Copland, E; Canoy, D; Wamil, M; Majert, J; McManus, RJ; Chalmers, J; Davis, BR (2021)